Target intelligence / Profile preview

Growth differentiation factor 11 messenger RNA 3'-untranslated region (GDF-11 mRNA 3'-UTR)

Target
GDF-11 mRNA 3'-UTR
Molecular classification
Nucleic acid, Messenger RNA regulatory region, Untranslated region (UTR)
01

Overview

The Growth differentiation factor 11 (GDF-11) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the GDF-11 transcript that controls the stability and translation of the GDF-11 protein, a member of the TGF-beta superfamily (UniProt P81101). GDF-11 is involved in regulating cell growth and differentiation, and its role in aging has been a subject of significant scientific debate, with some studies suggesting it reverses age-related cardiac hypertrophy while others indicate it inhibits muscle regeneration (Loffredo et al., 2013, Cell; Egerman et al., 2015, Cell Metabolism). The 3'-UTR serves as a docking site for various microRNAs, such as miR-128 and miR-34a, which post-transcriptionally repress GDF-11 expression (PubMed: 29153918, 25915404). Targeting this region with antisense oligonucleotides (ASOs) or microRNA mimics offers a therapeutic strategy to modulate GDF-11 levels in diseases like sarcopenia or heart failure. Because GDF-11 shares high sequence homology with Myostatin (GDF-8), the 3'-UTR provides a more specific target for genetic modulation than the protein's highly conserved signaling domain. However, the therapeutic application is challenged by the complex, context-dependent effects of GDF-11 signaling across different tissues and age groups.

Other names
GDF11 3'-UTRBone morphogenetic protein 11 mRNA 3'-untranslated regionBMP-11 mRNA 3'-UTRGDF-11 3'-UTR regulatory element
02

Mechanism of action

MicroRNA-mediated gene silencing, Antisense-mediated mRNA degradation, RNA interference (RNAi), Translational inhibition

03

Biological functions

Regulation of gene expressionmRNA stability regulationTranslational controlCell growth and differentiationAging and rejuvenation signaling
04

Disease associations

Cardiac hypertrophySarcopeniaSkeletal muscle atrophyAging-related regenerative declineFibrosis
05

Safety considerations

Off-target effects of RNA-based therapeuticsContradictory biological roles (pro-aging vs. anti-aging controversy)Potential for systemic TGF-beta superfamily cross-reactivityTissue-specific toxicity (e.g., skeletal muscle vs. cardiac muscle)
06

Interacting drugs

miR-128 (experimental)

3 more in the full profile.

07

Biomarkers

Circulating GDF-11 protein levelsGDF-11 mRNA expression levelsmiR-128 expression levels

Beyond the preview

Go deeper on Growth differentiation factor 11 messenger RNA 3'-untranslated region (GDF-11 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth differentiation factor 11 messenger RNA 3'-untranslated region (GDF-11 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call